Remedy Meds vs Wisp
Wisp costs $200 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Remedy Meds and Wisp, the first difference is cost: Wisp is $200 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Wisp leads our six-part score, 6.5 to 5.1. One of the two has an FDA warning letter on record, covered below.
Remedy Meds vs Wisp price
Wisp is the cheaper way in: $99 a month against $299 a month at Remedy Meds. That is $200 less each month (67% lower), or about $2,400 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Wisp ($225 a month vs $299 a month); tirzepatide is cheaper at Wisp ($99 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Remedy Meds prices compounded injections, while Wisp prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Wisp is the only one of the two with a brand-name price.
Where each one treats patients
Neither Remedy Meds nor Wisp publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Remedy Meds
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Both prices cover the medication itself and shipping.
Remedy Meds' price also covers the clinician visit, which Wisp does not claim.
Remedy Meds is silent on lab work and coaching.
Wisp is silent on the clinician visit, lab work and coaching.
Remedy Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Wisp scores 6.5 and Remedy Meds 5.1 out of 10.
Remedy Meds is stronger on support (7.0 vs 4.5).
Wisp is stronger on value (3.5 vs 3.0), user experience (8.0 vs 3.0) and trust & safety (6.5 vs 1.0).
Effectiveness and accessibility are within half a point.
Remedy Meds
5.1/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Remedy Meds a warning letter dated September 9, 2025 (letter 716830), and it is still open.
Wisp has no FDA warning letter on record with us.
Features & Coverage
| Feature | Remedy Meds | Wisp |
|---|---|---|
| Starting Price | $299/mo | ✓$99/mo |
| Features | 3 features | ✓8 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Remedy Meds
Remedy Meds sells compounded semaglutide and tirzepatide programs through telehealth.
Read our full Remedy Meds review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
Remedy Meds
What we like
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Remedy Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Wisp wins this one, 6.5 to 5.1, above all for an oral route if you will not self-inject. It also costs $200 less each month than Remedy Meds.
Choose Remedy Meds if…
You want broader feature coverage and an opening price near $299 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Remedy Meds vs Wisp: FAQ
Close alternatives to Remedy Meds and Wisp
- Remedy Meds vs Willow
- Remedy Meds vs Apex MD
- Remedy Meds vs Claya
- Remedy Meds vs Elevate Health
- Wisp vs GobyMeds
- Wisp vs HeliMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.